Drugs Made In America Acquisition DMII Ratios (2024-2026)

NASDAQ DMII
$10.16 +0.00 (+0.00%)
As of: Sep 10, 2026 · 3:07 PM EDT
Reported Financials

Drugs Made In America Acquisition Quarterly Ratios

Periods 4 quarters
Latest Jun 2026

Drugs Made In America Acquisition ratios data for the quarter ended Jun 2026. These financial ratios cover 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2024 Sep2025 Dec2025 Jun2026
Efficiency
Assets AverageAssets Avg. 250.57M502.98M509.53M
Invested CapitalInvested Cap. 0.13M-17.48M
Leverage & Solvency
Debt Ratio 1.810.00